Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sanofi Ord Shs SNYNF

Healthcare
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood... see more

Recent & Breaking News (OTCPK:SNYNF)

Multiple Sclerosis Association of America's Nationwide Search Uncovers Inspiring Stories of People Living with MS Who Swim for Better Health

PR Newswire March 18, 2014

Inactivated Polio Vaccines Broadly Available for the World's Children in the Drive Toward Polio Eradication

Canada NewsWire March 3, 2014

Genzyme Recognizes International Rare Disease Day with Global Awareness Programs and Launch of Fourth Annual Patient Advocacy Leadership (PAL) Awards

Business Wire February 28, 2014

Iconic brand Rolaids® is back, providing Canadians with much needed heartburn relief

Canada NewsWire February 27, 2014

First-of-Its-Kind Treatment for Relapsing-Remitting Multiple Sclerosis Now Available in Canada

Canada NewsWire February 27, 2014

New National Survey: Majority of Moms Hold Incorrect Beliefs About Head Lice Management and Treatment

PR Newswire February 26, 2014

Ardelyx Licenses NaP2b Phosphate Inhibitor Program for Kidney Disease to Sanofi in Deal Worth up to $198 Million

Marketwired February 24, 2014

A*STAR, NUS and NUH Join Forces to Understand Immune Erosion in Elderly

ACN Newswire February 12, 2014

Sanofi's CEO Admits Lackluster Drug Development Decade but Defends Its Pipeline: Sanofi (OTCQB: SNYNF), Royal Dutch Shell Plc (OTCQB: RYDAF), FUJIFILM Holdings Corp. (OTCPINK: FUJIY), Provectus Pharmaceuticals (OTC: PVCT)

Accesswire February 10, 2014

Sanofi Returns to Growth in Q4 2013

PR Newswire February 6, 2014

Sanofi FY 2013 - Interview with CEO Chris Viehbacher

Business Wire February 6, 2014

Sanofi Canada: A Partner in Health - Sanofi Canada recognized as one of Montreal's Top Employers

Canada NewsWire February 5, 2014

Sanofi's Consumer Healthcare Division Chattem Announces Nasacort® Allergy 24HR Nasal Spray Now Available Without a Prescription in the U.S.

PR Newswire February 4, 2014

Genzyme's Lemtrada® Approved in Mexico for Treatment of Multiple Sclerosis

Business Wire February 4, 2014

Federal Court Ruling Could Be Set Back for Royal Dutch Shell Stock: Royal Dutch Shell Plc (OTCQB: RYDAF), FUJIFILM Holdings Corp. (OTCPINK: FUJIY), Sanofi (OTCQB: SNYNF), Provectus Pharmaceuticals (OTC: PVCT)

Accesswire January 27, 2014

RDInvesting Provides Investors with Free In-Depth Equity Reports on AUXL, HPY, LAMR and SNY

Accesswire January 27, 2014

Sanofi Canada supports new Synvisc-One® brand ambassadors, Alexandre Bilodeau and Caroline Calvé

Canada NewsWire January 16, 2014

/R E P E A T -- Media Advisory / Photo Session and Interview Opportunity - Exclusive meeting with Alexandre Bilodeau, international athlete and new brand ambassador of Synvisc-One® by Sanofi Canada/

Canada NewsWire January 16, 2014

CORRECTION: Zealand announces advance by Sanofi of LixiLan, the single injection Lyxumia(r)/Lantus(r) combination product, towards Phase III development and a related milestone payment

Globe Newswire January 15, 2014

Finding Flexible Work Difficult for Cancer Patients and Caregivers

Canada NewsWire January 14, 2014